SEC Form 4 · accession 0001053369-16-000042
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerry Treppel
Other
Period of report
Jan 29, 2016
Accepted (ET)
Feb 18, 2016 · 7:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2016 | S | 115,000 | $0.35 | D | 9,081,769 | D | |
| Common Stock | Feb 1, 2016 | S | 312,300 | $0.34 | D | 8,769,469 | D | |
| Common Stock | Feb 2, 2016 | S | 13,000 | $0.33 | D | 8,756,469 | D | |
| Common Stock | Feb 3, 2016 | S | 45,518 | $0.33 | D | 8,710,951 | D | |
| Common Stock | Feb 4, 2016 | S | 349,660 | $0.32 | D | 8,361,291 | D | |
| Common Stock | Feb 5, 2016 | S | 24,400 | $0.33 | D | 8,336,891 | D | |
| Common Stock | Feb 16, 2016 | A | 124,646 | $0.2479 | A | 8,461,537 | D | |
| Common Stock | Feb 17, 2016 | S | 50,000 | $0.3116 | D | 8,411,537 | D |
Table II — derivative securities
No Table II lines on this filing.